Literature DB >> 23928943

Confocal microscopy in a case of crystalline keratopathy in a patient with smouldering multiple myeloma.

Cosimo Mazzotta1, Stefano Caragiuli, Aldo Caporossi.   

Abstract

We report the clinical and confocal microscopic findings of the cornea in a patient with smouldering multiple myeloma (SMM) using in vivo scanning laser confocal microscopy. A 72-year-old female underwent a complete ophthalmological examination including slit-lamp biomicroscopy with digital photography, HRT II laser scanning in vivo confocal microscopy and haematological laboratory assessment. Corneal biomicroscopy revealed the presence of bilateral diffuse microgranular tiny grey opacities. In vivo confocal microscopy showed randomly oriented hyper-reflective needle-shaped crystals throughout all levels of the stroma, sparing epithelium and endothelium. In vivo confocal microscopy was very helpful in the differential diagnosis by allowing the nature of the corneal deposits to be established, revealing the typical aspect of the crystals, and excluding granular dystrophy, leading to a suspected diagnosis of SMM. Crystalline corneal deposits may easily be confused as crumb-like opacities typical of granular dystrophy on slit-lamp examination even by experienced ophthalmologists.

Entities:  

Mesh:

Year:  2013        PMID: 23928943     DOI: 10.1007/s10792-013-9838-z

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  5 in total

1.  In vivo confocal microscopic findings of 2 patients with Bietti crystalline corneoretinal dystrophy.

Authors:  Banu Bozkurt; Banu T Ozturk; Hurkan Kerimoglu; Murat Irkec; Hamiyet Pekel
Journal:  Cornea       Date:  2010-05       Impact factor: 2.651

Review 2.  Differential diagnosis of Schnyder corneal dystrophy.

Authors:  Jayne S Weiss; Arbi J Khemichian
Journal:  Dev Ophthalmol       Date:  2011-04-26

3.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

4.  Rifabutin corneal deposits in a patient with acquired immunodeficiency syndrome: in vivo confocal microscopy investigation.

Authors:  Cosimo Mazzotta; Claudio Traversi; Elisabetta Nuti; Maria Caterina Sparano; Aldo Caporossi
Journal:  Eur J Ophthalmol       Date:  2009 May-Jun       Impact factor: 2.597

5.  Multiple myeloma and its ocular manifestations.

Authors:  A J Knapp; S Gartner; P Henkind
Journal:  Surv Ophthalmol       Date:  1987 Mar-Apr       Impact factor: 6.048

  5 in total
  4 in total

1.  In vivo confocal microscopy of verticillata-like paraproteinemic keratopathy in a patient with monoclonal gammopathy of uncertain significance evolving into smoldering multiple myeloma.

Authors:  Chiara Chierego; Tommaso Merz; Adriano Fasolo; Neil Lagali; Emilio Pedrotti
Journal:  Am J Ophthalmol Case Rep       Date:  2019-06-29

2.  Corneal Densitometry and In Vivo Confocal Microscopy in Patients with Monoclonal Gammopathy-Analysis of 130 Eyes of 65 Subjects.

Authors:  Kitti Kormányos; Klaudia Kovács; Orsolya Németh; Gábor Tóth; Gábor László Sándor; Anita Csorba; Cecília Nóra Czakó; László Módis; Achim Langenbucher; Zoltán Zsolt Nagy; Gergely Varga; László Gopcsa; Gábor Mikala; Nóra Szentmáry
Journal:  J Clin Med       Date:  2022-03-26       Impact factor: 4.241

Review 3.  Paraproteinemic keratopathy in monoclonal gammopathy of undetermined significance treated with primary keratoprosthesis: Case report, histopathologic findings, and world literature review.

Authors:  Homer H Chiang; Rebekah S Wieland; Thomas S Rogers; Pamela C Gibson; George Atweh; Gregory McCormick
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

4.  Recurrence of paraproteinemic keratopathy after penetrating keratoplasty and its assessment with confocal microscopy.

Authors:  J Wasielica-Poslednik; A Gericke; A Desuki; U Schlötzer-Schrehardt; N Pfeiffer; W Lisch
Journal:  Am J Ophthalmol Case Rep       Date:  2018-06-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.